Literature DB >> 10675703

Is bisacodyl absorbed at all from suppositories in man?

E Flig1, T W Hermann, M Zabel.   

Abstract

A HPLC procedure was developed to determine free BHPM in human plasma and urine after prior deconjugation of its glucuronides with glucuronidase. A single dose administration of a 10 mg bisacodyl suppository from Glaxo Wellcome, Poznań (Poland) to 16 volunteers each resulted in its low active metabolite (BHPM) plasma levels (10-55 microgram l(-1)) according to general assumptions. Its prompt laxative effect appeared within 56.6+/-10.8 min. The calculated serum half-life time of BHPM glucuronide excretion in urine was approximately 7.32+/-0.99 h. BHPM was excreted in urine in only 3. 36+/-0.52% if compared with the above bisacodyl rectal dose administered. Any relationship between BHPM plasma and/or urine levels and its laxative action does not occur. These results confirm the thesis that the laxative action of bisacodyl suppositories is initiated through a direct interaction of the drug in the rectum.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675703     DOI: 10.1016/s0378-5173(99)00385-3

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

1.  Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults.

Authors:  Amalia Diakidou; Maria Vertzoni; Konstantinos Goumas; Erik Söderlind; Bertil Abrahamsson; Jennifer Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2009-07-02       Impact factor: 4.200

Review 2.  Treating constipation during pregnancy.

Authors:  Magan Trottier; Aida Erebara; Pina Bozzo
Journal:  Can Fam Physician       Date:  2012-08       Impact factor: 3.275

3.  Effects of bisacodyl on ascending colon emptying and overall colonic transit in healthy volunteers.

Authors:  N Manabe; F Cremonini; M Camilleri; W J Sandborn; D D Burton
Journal:  Aliment Pharmacol Ther       Date:  2009-08-12       Impact factor: 8.171

Review 4.  Bisacodyl: A review of pharmacology and clinical evidence to guide use in clinical practice in patients with constipation.

Authors:  Maura Corsetti; Sabine Landes; Robert Lange
Journal:  Neurogastroenterol Motil       Date:  2021-03-09       Impact factor: 3.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.